| Basic and diluted loss per share |
Note 21 — Basic and diluted loss per share Basic EPS is measured as net loss divided by the weighted average common shares outstanding for the period. Diluted net loss per share attributable to common stockholders adjusts basic loss per share for the potentially dilutive impact of non-participating shares of common stock that are subject to the convertible note, and other securities outstanding. Certain securities may be anti-dilutive and would be excluded from the calculation of diluted loss per share and disclosed separately. Because of the nature of the calculation, particular securities may be dilutive in some periods and anti-dilutive in other periods. The following table presents the computation of basic and diluted loss per share attributable to common stockholders, for the periods presented: | | | For the Three Months Ended March 31, | | | For the Nine Months Ended March 31, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | Net loss– basic and diluted EPS | | $ | (36,269,993 | ) | | $ | (4,084,511 | ) | | $ | (43,421,349 | ) | | $ | (4,927,154 | ) | | | | | | | | | | | | | | | | | | | | Basic and diluted weighted average shares outstanding* | | | 6,989,278 | | | | 7,050,260 | | | | 6,886,673 | | | | 5,937,756 | | | | | | | | | | | | | | | | | | | | | Basic and diluted loss per share | | $ | (5.19 | ) | | $ | (0.58 | ) | | $ | (6.31 | ) | | $ | (0.83 | ) | | * | There were no shares that have a dilutive effect for the three and nine months ended March 31, 2026 and 2025. | The following table outlines dilutive common share equivalents outstanding, which are excluded in the above diluted net loss per share calculation, as the effect of their inclusion would be anti-dilutive or the share equivalents were contingently issuable as of each period presented: | | | For the Three Months Ended March 31, | | | For the Nine Months Ended March 31, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | Earnout Shares* | | | - | | | | 2,100,000 | | | | - | | | | 2,100,000 | | | Warrants ** | | | 12,145,917 | | | | 12,145,917 | | | | 12,145,917 | | | | 12,145,917 | | | RSUs** | | | 427,944 | | | | 727,009 | | | | 427,944 | | | | 727,009 | | | Total | | | 12,573,861 | | | | 14,972,926 | | | | 12,573,861 | | | | 14,972,926 | | | * | As described in Note 4 - Reverse recapitalization, the Earnout Shares that are contingently issuable in connection with the Business Combination are subject to vesting based on the Company’s financial performance during the earnout period. The Earnout Shares are excluded from the calculation of basic and diluted weighted-average number of common shares outstanding until vested. | | ** | The Company’s outstanding warrants and RSUs were excluded from the computation of diluted EPS because it has anti-dilutive effect as the company had a net loss during the periods presented. |
|